Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar 23:8:111-7.
doi: 10.2147/CEG.S57982. eCollection 2015.

Inflammatory bowel disease and anxiety: links, risks, and challenges faced

Affiliations
Review

Inflammatory bowel disease and anxiety: links, risks, and challenges faced

Ayman S Bannaga et al. Clin Exp Gastroenterol. .

Abstract

Inflammatory bowel disease (IBD) causes severe physical symptoms and is also associated with psychological comorbidities. Abnormal anxiety levels are found in up to 40% of patients with IBD. Anxiety symptoms are often related to flares of IBD but may persist in times of remission. Detection of anxiety disorder (AD) in patients with IBD can be challenging. Patients with anxiety may also exhibit symptoms in keeping with functional gastrointestinal disorders (FGID). Evidence for the effectiveness of pharmacological and psychological therapies for anxiety stems from patients without IBD. Studies in patients with IBD have either been small or shown negative results. In light of this, a combined approach involving IBD physicians to improve disease control and psychologists or psychiatrists to treat anxiety is advised. This review examines the evidence of anxiety issues in IBD with a focus on extent of the problem, risk factors for anxiety, and the effectiveness of interventions.

Keywords: Crohn’s disease; anxiety; inflammatory bowel disease; ulcerative colitis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Interaction between anxiety and IBD symptoms. Abbreviations: FGID, functional gastrointestinal disorders; IBD, inflammatory bowel disease.

References

    1. Podolsky D. Inflammatory bowel disease. N Engl J Med. 2002;347:417–429. - PubMed
    1. Kucharzik T, Maaser C, Lugering A, et al. Recent understanding of IBD pathogenesis: implications for future therapies. Inflamm Bowel Dis. 2006;12:1068–1083. - PubMed
    1. Sartor R. Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006;3:390–407. - PubMed
    1. The Publications Team Information about IBD. [Accessed December 6, 2014]. Available from: http://www.crohnsandcolitis.org.uk/information-and-support/information-a....
    1. Magalhães J, Castro F, Carvalho P, et al. Quality of life in patients with inflammatory bowel disease: importance of clinical, demographic and psychosocial factors. Arq Gastroenterol. 2014;51:192–197. - PubMed